Press Releases

Press Releases
  Date Title View
Sep 24, 2003
SOUTH SAN FRANCISCO, CA Date: September 24, 2003 Theravance, Inc., today announced that results from a series of eleven in vitro, in vivo, and human clinical studies with the investigational antibiotic TD-6424 were presented at the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chi...
Jan 6, 2003
SOUTH SAN FRANCISCO, CA and LONDON, UK Date: January 6, 2003 Theravance, Inc. and GlaxoSmithKline plc (LSE & NYSE: GSK) announced today that they have formed an alliance to develop and commercialize novel medicines containing long-acting Beta2 agonists (LABA) for the treatment of respiratory diseases, such as asthma and ch...
= add release to Briefcase


$14.83 0.46 (3.20%) 01/19/18 4:00 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.


Innoviva Investor Relations & Media

For business development inquiries,
please contact